Literature DB >> 33210238

Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer.

Catherine M Bender1, Susan M Sereika2, Amanda L Gentry2, Jennie E Duquette2, Frances E Casillo2, Anna Marsland3, Adam M Brufsky4, Steven Evans4, Vikram C Gorantla4, Tara L Grahovac5, Priscilla F McAuliffe4, Jennifer G Steiman4, Yehui Zhu2, Kirk I Erickson3.   

Abstract

Physical activity may improve cognitive function in women with breast cancer. In a cross-sectional study, we explored the relationship between cognitive function and physical activity (actigraph) and cardiorespiratory fitness (sub-maximal graded exercise test) in 73 postmenopausal women with early stage breast cancer prior to the initiation of systemic adjuvant therapy. Cognitive function was assessed with a standardized battery of neurocognitive measures assessing eight domains. Data were analyzed using partial correlations, controlling for age and total hours of actigraph wear-time. Women were, on average, 63.71 (± 5.3) years of age with 15.47 (± 2.48) years of education. For physical activity, greater average number of steps per day were associated with better attention (r = .262, p = .032) and psychomotor speed (r = .301, p = .011); greater average hours of moderate and moderate/vigorous intensity physical activity were associated with better visual memory (r = .241, p = .049; r = .241, p = .049, respectively); and greater average daily energy expenditure was associated with better visual memory (r = .270, p = .027) and psychomotor speed (r = .292, p = .017). For fitness, higher peak maximum VO2 was associated with better concentration (r = .330, p = .006), verbal memory (r = .241, p = .048), and working memory (r = .281, p = .019). These results suggest that higher levels of physical activity and cardiorespiratory fitness are associated with better cognitive function in postmenopausal women with breast cancer. Randomized controlled trials (RCT) to examine whether physical activity improves cognitive function in women with breast cancer are warranted. These RCTs should also determine the mechanisms of the influence of physical activity on cognitive function. CLINICAL TRIALS REGISTRATION NUMBER: NCT02793921; Date: May 20, 2016.

Entities:  

Keywords:  Breast cancer; Cardiorespiratory fitness; Cognitive function; Physical activity

Mesh:

Year:  2020        PMID: 33210238      PMCID: PMC8131400          DOI: 10.1007/s00520-020-05865-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  45 in total

Review 1.  Physical activity and risk of cognitive decline: a meta-analysis of prospective studies.

Authors:  F Sofi; D Valecchi; D Bacci; R Abbate; G F Gensini; A Casini; C Macchi
Journal:  J Intern Med       Date:  2010-09-10       Impact factor: 8.989

2.  Patterns of change in cognitive function with anastrozole therapy.

Authors:  Catherine M Bender; John D Merriman; Amanda L Gentry; Gretchen M Ahrendt; Sarah L Berga; Adam M Brufsky; Frances E Casillo; Meredith M Dailey; Kirk I Erickson; Frances M Kratofil; Priscilla F McAuliffe; Margaret Q Rosenzweig; Christopher M Ryan; Susan M Sereika
Journal:  Cancer       Date:  2015-04-23       Impact factor: 6.860

Review 3.  Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions.

Authors:  Arti Hurria; Lee Jones; Hyman B Muss
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.

Authors:  Carol E DeSantis; Stacey A Fedewa; Ann Goding Sauer; Joan L Kramer; Robert A Smith; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-10-29       Impact factor: 508.702

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.

Authors:  Arti Hurria; Sunita K Patel; Joanne Mortimer; Thehang Luu; George Somlo; Vani Katheria; Rupal Ramani; Kurt Hansen; Tao Feng; Carolyn Chuang; Cheri L Geist; Daniel H S Silverman
Journal:  Clin Breast Cancer       Date:  2013-10-25       Impact factor: 3.225

7.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

Review 8.  Cancer, physical activity, and exercise.

Authors:  Justin C Brown; Kerri Winters-Stone; Augustine Lee; Kathryn H Schmitz
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

9.  Cancer and cognitive changes: the complexity of the problem.

Authors:  Catherine M Bender; Bethany D Thelen
Journal:  Semin Oncol Nurs       Date:  2013-11       Impact factor: 2.315

10.  Cognitive function in breast cancer patients prior to adjuvant treatment.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Charlotte T Furstenberg; Bernard F Cole; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

View more
  2 in total

1.  Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer.

Authors:  Yu-Yin Allemann-Su; Marcus Vetter; Helen Koechlin; Steven M Paul; Bruce A Cooper; Kate Oppegaard; Michelle Melisko; Jon D Levine; Yvette Conley; Christine Miaskowski; Maria C Katapodi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 2.  Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care.

Authors:  Judith E Carroll; Julienne E Bower; Patricia A Ganz
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 65.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.